Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: Clinical implications

Journal of Urology

Volumn 170, Issue 1, 2003, Pages 12-19

  Larson, Benjamin T ^a   Bostwick, David G ^a   Corica, Alberto G ^a   Larson, Thayne R ^b  

^a BOSTWICK LABORATORIES   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Laser coagulation; Prostatic hyperplasia, prostatic neoplasms, transurethral resection of prostate; Ultrasound, high intensity focused, transrectal

Indexed keywords

ALCOHOL; COLLAGENASE; GENTAMICIN; HYALURONIDASE; ICE; PROSTATE SPECIFIC ANTIGEN; SODIUM CHLORIDE; TRITON X 100;

CELL DEATH; CRYOSURGERY; DEVICE; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; MALE; MINIMALLY INVASIVE SURGERY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; ULTRASOUND THERAPY;

EID: 0038002919     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000072200.22089.c3     Document Type: Review

References (82)

1. Gage, A. A. and Baust, J.: Mechanisms of tissue injury in cryo-surgery. Cryobiology, 37: 171, 1998
2. Bolmsjo, M., Sturesson, C., Wagrell, L., Andersson-Engels, S. and Mattiasson, A.: Optimizing transurethral microwave thermotherapy: a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol, 81: 811, 1998
3. Zlotta, A. R., Raviv, G., Peny, M.-O., Noel, J.-C., Haot, J. and Schulman, C. C.: Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J Urol, 157: 894, 1997
4. Brehmer, M. and Baba, S.: Transurethral microwave thermotherapy: how does it work? J Endourol, 14: 611, 2000
5. Barbalias, G. A. and Liatsikos, E. N.: Transrectal microwave hyperthermia for patients with benign prostatic hyperplasia. Int J Urol, 5: 157, 1998
6. Blute, M. L.: Microwave thermotherapy for the treatment of benign prostatic hyperplasia. Semin Urol, 12: 181, 1994
7. Blute, M. L. and Larson, T.: Minimally invasive therapies for benign prostatic hyperplasia. Urology, suppl., 58: 33, 2001
8. Daehlin, L. and Frugard, J.: Transurethral microwave thermotherapy in the management of lower urinary tract symptoms from benign prostatic obstruction: follow-up after five years. Scand J Urol Nephrol, 34: 304, 2000
9. Daehlin, L. and Frugard, J.: Three-year follow-up after transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia using the PRIMUS U + R device. Scand J Urol Nephrol, 33: 217, 1999
10. de la Rosette, J. J., de Wildt, M. J., Alivizatos, G., Froeling, F. M. and Debruyne, F. M.: Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology, 44: 58, 1994
11. de la Rosette, J. J., Francisca, E. A., Kortmann, B. B., Floratos, D. L., Debruyne, F. M. and Kiemeney, L. A.: Clinical efficacy of a new 30-min algorithm for transurethral microwave thermotherapy: initial results. BJU Int, 86: 47, 2000
12. de La Rosette, J. J., Laguna, M. P., Pace, G., Kortmann, B. B., Selvaggio, O., Debruyne, F. M. et al: Efficacy and safety of the new high-energy 30-minute transurethral microwave thermotherapy: results of 1-year follow-up in a multicenter study. Tech Urol, 6: 271, 2000
13. de Wildt, M. J., Wagrell, L., Larson, T. R. and Eliasson, T.: Clinical results of microwave thermotherapy for benign prostatic hyperplasia. J Endourol, 14: 651, 2000
14. Djavan, B. and Marberger, M.: Transurethral microwave thermotherapy: an alternative to medical management in patients with benign prostatic hyperplasia? J Endourol, 14: 661, 2000
15. Djavan, B., Seitz, C., Roehrborn, C. G., Remzi, M., Fakhari, M., Waldert, M. et al: Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology, 57: 66, 2001
16. Floratos, D. L., Alivizatos, G. J., Debruyne, F. M. and de la Rosette, J. J.: Transurethral microwave thermotherapy in the armamentarium of therapeutic modalities for benign prostatic hyperplasia. Tech Urol, 6: 256, 2000
17. Floratos, D. L., Sonke, G. S., Francisca, E. A., Kiemeney, L. A. L. M., Kortmann, B. B. M., Debruyne, F. M. J.: High energy transurethral microwave thermotherapy for the treatment of patients in urinary retention. J Urol, 163: 1457, 2000
18. Floratos, D. L., Sedelaar, J. P., Kortmann, B. B., Aarnink, R. G., Wijkstra, H., Debruyne, F. M.: Intra-prostatic vasculature studies: can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction? Prostate, 46: 200, 2001
19. Floratos, D. L., Kiemeney, L. A. L. M., Rossi, C., Kortmann, B. B. M., Debruyne, F. M. J. and de la Rosette, J. J. M. C. H.: Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol, 165: 1533, 2001
20. Floratos, D. L. and Aarnink, R. G.: Predictors of treatment outcome for high-energy transurethral microwave thermotherapy. J Endourol, 14: 643, 2000
21. Larson, T. R.: Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology, suppl., 59: 12, 2002
22. Larson, T. R., Collins, J. M. and Corica, A.: Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patients with benign prostatic hyperplasia. J Urol, 159: 258, 1998
23. Naqvi, S. A., Rizvi, S. A. and Hasan, A. S.: High-energy microwave thermotherapy in patients in urinary retention. J Endourol, 14: 677, 2000
24. Narayan, P. and Starling, J.: Minimally invasive therapies for the treatment of symptomatic benign prostatic hyperplasia: the University of Florida experience. J Clin Laser Med Surg, 16: 29, 1998
25. Terada, N., Aoki, Y., Ichioka, K., Matsuta, Y., Okubo, K., Yoshimura, K. et al: Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: response durability and variables potentially predicting response. Urology, 57: 701, 2001
26. Tsai, Y. S., Lin, J. S., Tong, Y. C., Tzai, T. S., Yang, W. H., Chang, H. L. et al: Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: long-term durability with Prostcare. Eur Urol, 39: 688, 2001
27. Wagrell, L., Schelin, T., Bolmsjo, M. B. and Mattiasson, A.: Aspects on transurethral microwave thermotherapy of benign prostatic hyperplasia. Tech Urol, 6: 251, 2000
28. Arai, Y., Aoki, Y., Okubo, K., Maeda, H., Terada, N., Matsuta, Y. et al: Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol, 164: 1206, 2000
29. Murayama, K. and Hisada, K.: Transurethral microwave thermotherapy for benign prostatic hyperplasia. Hinyokika Kiyo, 46: 799, 2000
30. Schelin, S.: Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention. Eur Urol, 39: 400, 2001
31. Djavan, B. and Marberger, M.: Minimally invasive procedures as an alternative to medical management for lower urinary tract symptoms of benign prostatic hyperplasia. Curr Opin Urol, 11: 1, 2001
32. Larson, T. R., Rrobertson, D. W., Corica, A. and Bostwick, D. G.: In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology, 55: 547, 2000
33. Ravery, V.: Transurethral microwave thermotherapy v transurethral resection of prostate. J Endourol, 14: 693, 2000
34. Larson, T. R., Bostwick, D. G. and Corica, A.: Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. Urology, 47: 463, 1996
35. Osman, Y. M., Larson, T. R., El-Diasty, T. and Ghoneim, M. A.: Correlation between central zone perfusion defects on gadolinium-enhanced MRI and intraprostatic temperatures during transurethral microwave thermotherapy. J Endourol, 14: 761, 2000
36. Chapple, C. R., Issa, M. M. and Woo, H.: Transurethral needle ablation (TUNA). A critical review of radiofrequency thermal therapy in the management of benign prostatic hyperplasia. Eur Urol, 35: 119, 1999
37. Minardi, D., Garofalo, F., Yehia, M., Cristalli, A. F., Giammarco, L., Galosi, A. B. et al: Pressure-flow studies in men with benign prostatic hypertrophy before and after treatment with transurethral needle ablation. Urol Int, 66: 89, 2001
38. Namiki, K., Shiozawa, H., Tsuzuki, M., Mamiya, Y., Matsumoto, T. and Miki, M.: Efficacy of transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia. Int J Urol, 6: 341, 1999
39. Rasor, J. S., Zlotta, A. R., Edwards, S. D. and Schulman, C. C.: Transurethral needle ablation (TUNA): thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol, 24: 411, 1993
40. Roehrborn, C. G., Issa, M. M., Bruskewitz, R. C., Naslund, M. J., Oesterling, J. E., Perez-Marrero, R. et al: Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology, 51: 415, 1998
41. Schatzl, G., Madersbacher, S., Djavan, B., Lang, T. and Marberger, M.: Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options. Eur Urol, 37: 695, 2000
42. Schulman, C. C. and Zlotta, A. R.: Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure tor treatment of benign prostatic hyperplasia. Prog Clin Biol Res, 386: 479, 1994
43. Ramon, J., Lynch, T. H., Eardley, I., Ekman, P., Frick, J., Jungwirth, A. et al: Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol, 80: 128, 1997
44. Bruskewitz, R., Issa, M. M., Roehrborn, C. G., Naslund, M. J., Perez-Marrero, R., Shumaker, B. P. et al: A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol, 159: 1588, 1998
45. Beerlage, H. P., van Leenders, G. J., Oosterhof, G. O., Witjes, J. A., Ruijter, E. T., van de Kaa, C. A. et al: High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate, 39: 41, 1999
46. Madersbacher, S., Schatzl, G., Djavan, B., Stulnig, T. and Marberger, M.: Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol, 37: 687, 2000
47. Sullivan, L., Casey, R. W., Pommerville, P. J. and Marich, K. W.: Canadian experience with high intensity focused ultrasound for the treatment of BPH. Can J Urol, 6: 799, 1999
48. Uchida, T., Muramoto, M., Kyunou, H., Iwamura, M., Egawa, S. and Koshiba, K.: Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. Urology, 52: 66, 1998
49. Susani, M., Madersbacher, S., Kratzik, C., Vingers, L. and Marberger, M.: Morphology of tissue destruction induced by focused ultrasound. Eur Urol, suppl., 23: 34, 1993
50. Muschter, R. and Whitfield, H.: Interstitial laser therapy of benign prostatic hyperplasia. Eur Urol, 35: 147, 1999
51. Mueller-Lisse, U. G., Thoma, M., Faber, S., Heuck, A. F., Muschter, R., Schneede, P. et al: Coagulative interstitial laser-induced thermotherapy of benign prostatic hyperplasia: online imaging with a T2-weighted fast spin-echo MR sequence - experience in six patients. Radiology, 210: 373, 1999
52. Volpe, M. A., Fromer, D. and Kaplan, S. A.: Holmium and interstitial lasers for the treatment of benign prostatic hyperplasia: a laser revival. Curr Opin Urol, 11: 43, 2001
53. Zlotta, A. R. and Schulman, C. C.: Interstitial laser coagulation for the treatment of benign prostatic hyperplasia using local anaesthesia only. BJU Int, 83: 341, 1999
54. Arai, Y., Okubo, K., Okada, T., Maekawa, S., Aoki, Y. and Maeda, H.: Interstitial laser coagulation for management of benign prostatic hyperplasia: a Japanese experience. J Urol, 159: 1961, 1998
55. Costello, A. J. and Kabalin, J. N.: Side-firing Neodymium:YAG laser prostatectomy. Eur Urol, 35: 138, 1999
56. Costello, A. J., Bolton, D. M., Ellis, D. and Crowe, H.: Histopathological changes in human prostatic adenoma following neodymium:YAG laser ablation therapy. J Urol, 152: 1526, 1994
57. Muschter, R., Schorsch, I., Danielli, L., Russel, C., Timoney, A., Yachia, D. et al: Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol, 164: 1565, 2000
58. Corica, F. A., Cheng, L., Ramnani, D., Pacelli, A., Weaver, A., Corica, A. G. et al: Transurethral hot-water balloon thermoablation for benign prostatic hyperplasia: patient tolerance and pathologic findings. Urology, 56: 76, 2000
59. Gutierrez, J. S. et al: Histological changes of the prostate gland after transurethral ethanol ablation. Eur Urol, suppl., 1: 130, abstract 509, 2002
60. Badlani, G.: Transurethral ethanol ablation of the prostate (TEAP): review of two multicentre studies. J Endourol, suppl., 1: 130, abstract 512, 2002
61. Pauer, P. et al: Transurethral ethanol ablation of the prostate (TEAP), initial report of a prospective multi-centre study. J Endourol, suppl., 1: 130, abstract 511, 2002
62. Palmer, J.: Prostaject ethanol: injection therapy for BPH - 12 month results. J Endourol, suppl., 2002
63. Larson, T. N. P. P. and Huidobro, C.: Controlled tissue ablation using chemo-gel injection under ultrasound/MRI guidance. J Endourol, suppl., p. A47, abstract p11-2, 2001
64. Larson, T. N., Huidobro, C. and Palma, P.: Intraprostatic injection of ETOH gel for treatment of BPH: preliminary clinical results. J Endourol, suppl., p. A132, abstract p. 23-26, 2001
65. Harmon, W. J., Barrett, D. M., Qian, J., Lauvetz, R. W., Bostwick, D. G. and Gocken, M.: Transurethral enzymatic ablation of the prostate: canine model. Urology, 48: 229, 1996
66. Zisman, A., Pantuck, A. J., Cohen, J. K. and Belldegrun, A. S.: Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology, 58: 988, 2001
67. Saliken, J. C., Donnelly, B. J., Ernst, S., Rewcastle, J. and Wiseman, D.: Prostate cryotherapy: practicalities and applications from the Calgary experience. Can Assoc Radiol J, 52: 165, 2001
68. Long, J. P., Bahn, D., Lee, F., Shinohara, K., Chinn, D. O. and Macaluso, J. N., Jr.: Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology, 57: 518, 2001
69. Leibovici, D., Zisman, A., Siegel, Y. I. and Lindner, A.: Cryosurgical ablation for prostate cancer: preliminary results of a new advanced technique. Isr Med Assoc J, 3: 484, 2001
70. Ghafar, M. A., Johnson, C. W., De La Taille, A., Benson, M. C., Bagiella, E., Fatal, M. et al: Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol, 166: 1333, 2001
71. Donnelly, B. J., Saliken, J. C., Ali-Ridha, N., Rewcastle, J. C. and White, L. J.: Histological findings in the prostate two years following cryosurgical ablation. Can J Urol, 8: 1237, 2001
72. Clarke, D. M., Baust, J. M., Van Buskirk, R. G. and Baust, J. G.: Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology, 42: 274, 2001
73. Zisman, A., Leibovici, D., Siegel, Y. I. and Lindner, A.: Prostate cryoablation without an insertion kit using direct transperineal placement of ultrathin freezing probes. Tech Urol, 6: 34, 2000
74. De La Taille, A., Benson, M. C., Bagiella, E., Burchardt, M., Shabsigh, A., Olsson, C. A. et al: Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int, 85: 281, 2000
75. Koppie, T. M., Shinohara, K., Grossfeld, G. D., Presti, J. C., Jr. and Carroll, P. R.: The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol, 162: 427, 1999
76. Gould, R. S.: Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery. J Urol, 162: 1653, 1999
77. Tucker, R. D., Platz, C. E., Huidobro, C. and Larson, T.: Interstitial thermal therapy in patients with localized prostate cancer: histologic analysis. Urology, 60: 166, 2002
78. Sherar, M. D., Gertner, M. R., Yue, C. K. K., O'Malley, M. E., Toi, A., Gladman, A. S. et al: Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. J Urol, 166: 1707, 2001
79. Khair, A. A., Pacelli, A., Iczkowski, K. A., Cheng, L., Corica, F. A., Larson, T. R. et al: Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue? Urology, 54: 67, 1999
80. Chaussy, C. G. and Thuroff, S.: High-intensive focused ultrasound in localized prostate cancer. J Endourol, 14: 293, 2000
81. Van Leenders, G. J., Beerlage, H. P., Ruijter, E. T., de la Rosette, J. J. and van de Kaa, C. A.: Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol, 53: 391, 2000
82. Gelet, A., Chapelon, J. Y., Bouvier, R., Rouviere, O., Lasne, Y., Lyonnet, D. et al: Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol, 14: 519, 2000